Select Region
Home
Top 10
Important Product Safety InformationAlert: Product and Safety Notice

MiniMed™ 670G Insulin Pump System

Inspiring confidence.
The world’s first HYBRID CLOSED LOOP SYSTEM.


The MiniMed™ 670G system offers SmartGuard™, the only technology that mimics some of the functions of a healthy pancreas by providing two new levels of automated insulin delivery.


  Watch Video

MiniMed 670G System

SmartGuard™ features:

AUTO MODE‡

  • Automatically adjusts your basal (background) insulin every five minutes based on your CGM readings.*,#
  • Helps keep your sugar levels in your target range for fewer lows and highs — day and night.*,#,1

  See how Auto Mode works


SUSPEND BEFORE LOW§

  • Stops insulin up to 30 minutes before reaching your preset low limits.
  • Automatically restarts insulin when your levels recover without bothersome alerts.#
  • Helps you avoid lows and rebound highs.1

  See how Suspend Before Low works

Nothing’s more inspiring than
more freedom.

Sleeping soundly. Waking up energized.

Sleeping soundly. Waking up energized.
The MiniMed™ 670G system lets you wake up every morning well-rested and ready to take on the day.

Living life more spontaneously

Living life more spontaneously.
Instead of injecting insulin many times a day, the MiniMed™ 670G system helps keep your sugar levels safely in range based on how you live every day.*,#

Enjoying meals without interruption

Enjoying meals without interruption.
Instead of figuring out complex insulin doses on your own, simply check your glucose and enter the number of carbs when you give a mealtime bolus. The MiniMed™ 670G system assists with the rest, automatically∆ adjusting insulin while you enjoy your meal without interruption.*,#

Having more time for family and friends

Having more time for family and friends.
Now you can spend less time worrying and more time bonding with family and friends. To help you stay in range, the MiniMed™ 670G system delivers insulin based on your sugar levels 24 hours a day with minimal input and periodic sensor calibration.*,#

The MiniMed™ 670g system.


Water Resistance Waterproof pump, protected against the effects of being underwater to a depth of up to 12 feet (3.6 meters) for up to 24 hours.
Sizing The pump dimensions in inches are approximately 2.1 width x 3.78 length x 0.96 depth. The weight of the pump is approximately 3 ounces.
Environmental Conditions The MiniMed 670G insulin pump system is designed to withstand most conditions encountered in your daily life. Pump storage temperature range is from -4 °F (-20 °C) to 122 °F (50 °C). Air pressure range is from 700 hPa to 1060 hPa (10.2 psi to 15.4 psi)
Pump Memory At any time the user can review 90 days of pump history
Compatible Infusion Sets Medtronic Diabetes provides a variety of infusion sets to fit your needs.
Guardian Link 3 Transmitter Used with your pump for Continuous Glucose Monitoring (CGM). A device that connects to a glucose sensor. The transmitter collects data measured by the sensor and wirelessly sends this data to monitoring devices.
Bolus Speed Options
  • Standard: 1.5 units/minute
  • Quick: 15 units/minute
Bolus Programming Increments
  • 0.025 units
  • 0.05 units
  • 0.1 units
Altitude Range
  • Pump operating range is from 10.2 psiA (70.33 kPa) to 15.4 psiA (106.18 kPa)
  • Storage range is from 7.2 psiA (49.64 kPa) to 15.4 psiA (106.18 kPa)
Backlight
  • Type LED (Light-emitting Diode)
  • Time out 15 seconds (default), 30 seconds, one minute, three minutes
  • Time out when battery is low 15 seconds (default), 30 seconds
Basal Delivery Rate Range 0 to 35 units per hour or the Max Basal Rate amount, whichever is lower.
Guardian Sensor 3 Used with your pump for CGM. The sensor is a small part of the continuous glucose monitoring system that you insert just below your skin to measure glucose levels in your interstitial fluid.
CareLink™ USB Used to upload system data to the diabetes management software using a USB port on your computer.
One-press Serter The serter is used as an aid for inserting the sensor. It is indicated for single-patient use and is not intended for multiple patient use.
Battery & Power The pump requires one new AA (1.5 V) battery. For best results, use a new AA lithium (FR6) battery. The pump also accepts an AA alkaline (LR6) or a fully charged AA NiMH (HR6) nickel-metal hydride rechargeable battery.
Reservoir Medtronic reservoir MMT-332A, 3.0 ml (300-unit)
CONTOUR® NEXT LINK 2.4 Glucose Meter The MiniMed 670G system comes with a compatible meter. It wirelessly connects to your pump, allowing you to send BG meter readings to your pump.

MiniMed 670G Accessories
TO FIT YOUR STYLE & LIFE.


Shop Accessories

MiniMed 670G Accessories

BELTS AND POUCHES

Soft belts and pouches can be sized for the perfect fit and give you a comfortable way to keep your pump close and concealed. They can be worn on different parts of your body — the waist, leg, thigh or arm — discreetly under clothing.


CASES AND CLIPS

With our selection of cases and clips, there are many ways to wear your insulin pump. You can attach your pump to your waistband or belt, protect it in your pocket, or even clip it under clothing.

Meet real people
like you on the
MINIMED™ 670G SYSTEM WITH SMARTGUARD TECHNOLOGY.

With the MiniMed™ 670G system helping Nicky stay in range∆, every waking moment is a new opportunity to spend quality time with her family and friends. Now she can fully enjoy horseback riding, soccer and sleepovers — all the things that help make her an active, confident teenager.

 
Nicky
Diagnosed at aged 10
Medtronic customer since 2015

Nikhita and her sister researched technology options available to manage her diabetes. When they discovered that the MiniMed™ 670G system with SmartGuard™ technology automatically¶, ∆ adjusts insulin to help keep glucose levels in range 24 hours a day, they knew it was the right fit.

 
Nikhita
Diagnosed at aged 5
Medtronic customer since 2007

With new information to optimize his glucose levels when he travels for work, John has become the confident traveler he always wanted to be. His wife sleeps better now, knowing that his glucose levels are stabilized automatically∆ with SmartGuard™ technology.

 
John
Diagnosed at aged 16
Medtronic customer since 2009

The MiniMed™ 670G system with SmartGuard™ technology automatically∆ helps keep both Joanne and her son in range, day and night. Joanne isn’t as worried about long-term complications from diabetes anymore, and she sees a bright future for her son.

 
Joanne
Diagnosed at aged 5
Medtronic customer since 1991

With his glucose in range no matter where he is, Ryan’s getting his first true taste of independence. His mom feels comfortable letting him travel with his hockey team and Ryan can enjoy life as a teenager even more.

 
Ryan
Diagnosed at aged 12∆
Medtronic customer since 2013

NOW NICKY HAS MORE TIME TO ENJOY
EVERY MOMENT OF EVERY DAY.

NICKY'S
A1C.

BEFORE
8.5
AFTER
7.9
**Representative of actual patient
Carelink™ data. Individual results may vary.

FEWER LOWS
& MORE TIME IN RANGE.

SmartGuard™ technology helps keep Nicky’s glucose levels in check, so she is free to plan her next sleepover with friends.

IN RANGE: 70-180 mg/dL
HIGH: 180-400 mg/dL
LOW: <70 mg/dL

NOW NIKHITA HAS FEWER LOWS AND
MORE ENERGY IN THE EVENING.

NIKHITA'S
A1C.

BEFORE
AFTER
**Representative of actual patient
Carelink™ data. Individual results may vary.

FEWER LOWS.
LESS WORRY.

SmartGuard™ technology, Nikhita experiences fewer glucose lows, and her glucose levels are more steady, so she can focus more on school and her next tennis match.

IN RANGE: 70-180 mg/dL
HIGH: 180-400 mg/dL
LOW: <70 mg/dL

JOHN HAS FEWER HIGHS AND LOWS,
ENJOYING LIFE TO THE MAX.

JOHN'S
A1C.

BEFORE
8.1
AFTER
6.1
**Representative of actual patient
Carelink™ data. Individual results may vary.

HELPS IMPROVE
TIME IN RANGE.

With SmartGuard™ technology, John’s glucose levels are automatically∆ adjusted, so he is free to live life more in the moment.

IN RANGE: 70-180 mg/dL
HIGH: 180-400 mg/dL
LOW: <70 mg/dL

JOANNE WAKES UP RESTED
READY TO CONQUER THE DAY.

JOANNE'S
A1C.

BEFORE
8.7
AFTER
7.6
**Representative of actual patient
Carelink™ data. Individual results may vary.

HELPS IMPROVE
TIME IN RANGE.

With SmartGuard™ technology, Joanne notices that she spends more time in range. That’s because her insulin levels are automatically∆ adjusted based on her needs.

IN RANGE: 70-180 mg/dL
HIGH: 180-400 mg/dL
LOW: <70 mg/dL

WITH FEWER GLUCOSE HIGHS,
RYAN GETS TO ENJOY
MORE TIME WITH HIS FRIENDS.

RYAN'S
A1C.

BEFORE
8.4
AFTER
7.8
**Representative of actual patient
Carelink™ data. Individual results may vary.

FEWER HIGHS.
LESS WORRY.

With SmartGuard™ technology, Ryan’s insulin levels are automatically¶, ∆ adjusted, so he can live more in the moment with friends.

Upgrade to the
MiniMed™ 670G System today.


To learn more about your eligibility and potential out-of-pocket costs, call 1-888-350-5440 or complete the form below and we’ll help get you started with a free insurance coverage check.



       

AUTHORIZATION FOR USE OF PROTECTED HEALTH INFORMATION

You authorize Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes or its subsidiaries, contractors or representatives to use your personal information, including but not limited to your contact information and health information, for marketing purposes and to share that information with Medtronic representatives and contractors. Information you may receive includes, but is not limited to: (a) Medtronic Diabetes products, therapies or services; (b) marketing and promotional offers; (c) inquiries about your experience with Medtronic Diabetes products, therapies and services; and/or (d) suggestions for how Medtronic Diabetes can enhance its customer support.

This authorization will expire three (3) years from the later of the date you submit this authorization online; or (ii) the last date products or services were received from Medtronic, but may expire sooner if you revoke it by following the instructions below.

You have the right to revoke this authorization at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating my communication preferences at www.diabetes.shop/myhome. A revocation will not affect actions Medtronic Diabetes has already taken based on this authorization. Information disclosed pursuant to this authorization may be re-disclosed by the recipient of the information and may no longer be protected by the federal privacy standards.

You have the right to refuse to sign this authorization. Refusal to sign will not affect your treatment or health insurance eligibility or benefits.

Questions? Contact our Customer Service Center at 800-646-4633, or by email at takecontrol@medtronic.com.

CONSENT FOR RECEIPT OF PHONE COMMUNICATIONS

You consent to receiving phone calls, including pre-recorded and auto-dialed communications, at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes, concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/myhome).

CONSENT FOR RECEIPT OF TEXT COMMUNICATIONS

You consent to receiving text messages at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes, concerning the marketing, advertising and/or offers of sale of Medtronic Diabetes products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for Medtronic Diabetes to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) texting "STOP" in return to a text; (ii) sending an email to takecontrol@medtronic.com; or (iii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/myhome).


Inspiring news.
Read all about it.


“A life-changing breakthrough.”

“This device will mean peace of mind, in knowing a person will be in normal blood sugar range a great majority of the time,”

“Automated insulin delivery system will ease some of the burden of living with the condition”

One of "the 25 best inventions of 2016”

“We applaud the @US_FDA's approval of the first hybrid insulin delivery system.”

“It’s a medical device with the potential to change the lives of more than 1 million Americans who suffer from Type 1 diabetes.”

“A groundbreaking new device could change the lives of millions of people living with diabetes.”

Meet the MiniMed Ambassadors.


MiniMed Ambassadors are people living with diabetes and using Medtronic products. They’re available to have honest one-to-one conversations with you or your loved ones about their experiences.

If you have questions regarding the MiniMed™ 670G system and how it may fit into your daily life, an Ambassador is just an email away and ready to answer your questions.

View all Ambassadors

Services
you need,
when you need them.

 

Training & Education

We offer personal training, tailored to help you get the most from your MiniMed™ 670G system. Count on expert support from diabetes educators, therapy consultants and clinical specialists.


>

StartRightSM Program

Our free coaching program helps you get started. Your StartRightSM representative prepares you for upcoming product training, setting diabetes therapy goals and tracking progress.


>

Global Assistance

When you travel with your MiniMed 670G system, get access to our global support network. We’ve got you covered in more than 100 countries worldwide.


>

* Mean Absolute Relative Difference.
** 3-4 calibrations per day required.
¶ Some user interaction required.
# Based on sensor glucose.
∆ Refers to AutoMode. Some interaction required. Individual results may vary.
† The pump is protected against the effects of continuous immersion in up to 12 feet (3.6 meters) of water for up to 24 hours at a time at the time of manufacture. This is classified as IPX8 rating. See user guide for more details.
∆ Indicated for type 1 patients seven years of age or older.

§ WARNING: Do not use the Suspend on low feature to prevent or treat low glucose. Always confirm your sensor glucose reading using your BG meter, and follow the instructions of your healthcare professional to treat low glucose. Using Suspend on low alone to prevent or treat low glucose may result in prolonged hypoglycemia..

‡ WARNING: Do not use Auto Mode for a period of time after giving a manual injection of insulin by syringe or pen. Manual injections are not accounted for in Auto Mode. Therefore, Auto Mode could deliver too much insulin. Too much insulin may cause hypoglycemia. Consult with your healthcare professional for how long you need to wait after a manual injection of insulin before you resume Auto Mode.

References

1. Bailey T, et al. Accuracy, Precision, and User Performance Evaluation of the CONTOUR®NEXT LINK 2.4 Blood Glucose Monitoring System. Poster presented at the 7th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD); 2014 February 5–8, Vienna, Austria.

Important Safety Information: MiniMed™ 670G System

The Medtronic MiniMed™ 670G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons, seven years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 670G system includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitor sensor glucose values, and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values. The system requires a prescription. The Guardian Sensor (3) glucose values are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. A confirmatory finger stick test via the CONTOUR®NEXT LINK 2.4 blood glucose meter is required prior to making adjustments to diabetes therapy. All therapy adjustments should be based on measurements obtained using the CONTOUR®NEXT LINK 2.4 blood glucose meter and not on values provided by the Guardian Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the CONTOUR®NEXT LINK 2.4 blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site (palm) or from a control solution test. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise. If a control solution test is out of range, please note that the result may be transmitted to your pump when in the “Always” send mode.

WARNING: Medtronic performed an evaluation of the MiniMed™ 670G system and determined that it may not be safe for use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore this device should not be used in anyone under the age of 7 years old. This device should also not be used in patients who require less than a total daily insulin dose of 8 units per day because the device requires a minimum of 8 units per day to operate safely.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 670G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety-information#minimed-670g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library.

By submitting this form, you are granting Medtronic MiniMed, Inc. ("Medtronic") permission to add your contact information to its database for sending you additional information and communications related to Medtronic products and therapies. You may revoke this permission at any time by e-mailing takecontrol@medtronic.com or by sending a request in writing to: Medtronic MiniMed, Inc. c/o Customer Support, 18000 Devonshire Street, Northridge, CA 91325-1219. Medtronic respects and upholds the confidentiality of your personal information. We will not share your personal information with any third-parties, except as otherwise noted in our Website Privacy Policy here: www.medtronicdiabetes.com/privacy-policy

MiniMed is a registered trademark and SmartGuard is a trademark of Medtronic, MiniMed Inc.

© 2018 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. Ascensia, the Ascensia Diabetes Care logo, and Contour are trademarks and/or registered trademarks of Ascensia Diabetes Care.